Cardiovascular disease after renal transplantation
- PMID: 8808124
- DOI: 10.1681/ASN.V71158
Cardiovascular disease after renal transplantation
Abstract
Although cardiovascular disease is a major cause of morbidity and mortality after renal transplantation, its pathogenesis and treatment are poorly understood. We conducted separate analyses of risk factors for ischemic heart disease, cerebral, and peripheral vascular disease after 706 renal transplants, all of which functioned for at least 6 months. We used Cox proportional hazards analysis to examine the effects of multiple pretransplant and posttransplant risk factors and included time-dependent variables measured at 3, 6, and 12 months, and annually to last follow-up at 7.0 +/- 4.2 yr. The independent relative risk (RR) of diabetes was 3.25 for ischemic heart disease, 3.21 for cerebral vascular disease, and 28.18 peripheral vascular disease (P < 0.05). The RR of each acute rejection episode was 1.40 for ischemic heart disease and 1.24 for cerebral vascular disease. Among serum lipid levels, high-density lipoprotein cholesterol was the best predictor of ischemic heart disease (RR = 0.80 for each 10 mg/dL). Posttransplant ischemic heart disease was strongly predictive of cerebral (5.80) and peripheral vascular disease (5.22), whereas ischemic heart disease was predicted by posttransplant cerebral (8.25) and peripheral vascular disease (4.58). Other risk factors for vascular disease included age, gender, cigarette smoking, pretransplant splenectomy, and serum albumin. Hypertension and low-density lipoprotein cholesterol had no effect, perhaps because of aggressive pharmacologic treatment. Thus, the incidence of cardiovascular disease continues to be high after renal transplantation, and multiple risk factors suggest a number of possible strategies for more effective treatment and prevention.
Similar articles
-
[Incidence of cardiovascular risk factors and complications after kidney transplantation].Med Klin (Munich). 1999 Sep 15;94(9):478-84. doi: 10.1007/BF03044939. Med Klin (Munich). 1999. PMID: 10544610 German.
-
Cardiovascular risk factors and diseases after renal transplantation.Int Urol Nephrol. 1998;30(6):777-88. doi: 10.1007/BF02564867. Int Urol Nephrol. 1998. PMID: 10195874
-
Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study.Am J Kidney Dis. 2019 Apr;73(4):476-485. doi: 10.1053/j.ajkd.2018.12.023. Epub 2019 Jan 28. Am J Kidney Dis. 2019. PMID: 30704880
-
Risk factors for cardiovascular disease after renal transplantation.Miner Electrolyte Metab. 1993;19(3):186-95. Miner Electrolyte Metab. 1993. PMID: 8232106 Review.
-
Pretransplant cardiovascular evaluation and posttransplant cardiovascular risk.Kidney Int Suppl. 2010 Sep;(118):S1-7. doi: 10.1038/ki.2010.209. Kidney Int Suppl. 2010. PMID: 20706223 Review.
Cited by
-
Cardiovascular risk stratification after renal transplant: Is SPECT-MPI the answer?J Nucl Cardiol. 2017 Feb;24(1):304-307. doi: 10.1007/s12350-016-0705-y. Epub 2016 Oct 28. J Nucl Cardiol. 2017. PMID: 27796850 No abstract available.
-
Kidney transplantation in patients with type 1 diabetes mellitus: long-term prognosis for patients and grafts.Korean J Intern Med. 2001 Jun;16(2):98-104. doi: 10.3904/kjim.2001.16.2.98. Korean J Intern Med. 2001. PMID: 11590909 Free PMC article.
-
The efficacy and safety of ezetimibe and low-dose simvastatin as a primary treatment for dyslipidemia in renal transplant recipients.Korean J Intern Med. 2009 Sep;24(3):233-7. doi: 10.3904/kjim.2009.24.3.233. Epub 2009 Aug 26. Korean J Intern Med. 2009. PMID: 19721860 Free PMC article.
-
A practical guide to the management of hypertension in renal transplant recipients.Drugs. 1999 Dec;58(6):1011-27. doi: 10.2165/00003495-199958060-00005. Drugs. 1999. PMID: 10651388 Review.
-
The effect of fluvastatin of hyperlipidemia in renal transplant recipients: a prospective, placebo-controlled study.Int Urol Nephrol. 2001;32(4):713-6. doi: 10.1023/a:1015052312866. Int Urol Nephrol. 2001. PMID: 11989571 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical